TOP TIERMARKET NEWSWIRE
Movers explained · October 20, 2026

Why Is MYRIAD GENETICS INC (MYGN) Stock Moving Today?

By the Top Tier Newswire AI Desk · reviewed against 12 wire stories

MYRIAD GENETICS INC (MYGN) is drawing unusual attention today. Our newswire has captured 12 stories on MYGN across 8 sources in the last 36 hours, with AI sentiment reading bullish (avg 60/100).

Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.

The written analysis for MYGN publishes to the public page once it clears the 4-hour delay. The coverage, sentiment and session data below are already here.

MYGN by the numbers

Coverage: 12 stories / 8 sourcesAI sentiment: 60/100 (bullish)
AI sentiment, last 36h · averaged over 12 stories · 60/100 bullish
AI sentiment 60/100 (bullish)0 · bearish50bullish · 100

The headlines behind the move

Story flow · 10 stories on the wire, last 36h · hover or tap a dot for the headline
36h ago24h ago12h agonowThe Fly · sentiment 58 · Myriad Genetics to sell Prenatal Health testing business to LabcorpThe Fly · 58Myriad Genetics to sell Prenatal Health testing business to LabcorpTipRanks · sentiment 44 · Myriad Genetics to Divest Prenatal Testing BusinessTipRanks · 44Myriad Genetics to Divest Prenatal Testing BusinessInvesting.com Markets · sentiment 64 · Why is Myriad Genetics stock surging today?Investing.com Markets · 64Why is Myriad Genetics stock surging today?Seeking Alpha · sentiment 64 · Myriad to sell prenatal health testing business to Labcorp for $210MSeeking Alpha · 64Myriad to sell prenatal health testing business to Labcorp for $210MMarketChameleon · sentiment 64 · Myriad Genetics strikes $210 million prenatal testing divestiture to sharpen focus on cancer care priorities October 20, 2026MarketChameleon · 64Myriad Genetics strikes $210 million prenatal testing divestiture to sharpen focus on can…MarketChameleon · sentiment 64 · MYGN jumps as Myriad agrees to sell Prenatal Health testing business to Labcorp for $210 million cashMarketChameleon · 64MYGN jumps as Myriad agrees to sell Prenatal Health testing business to Labcorp for $210 …Investing.com Markets · sentiment 74 · Myriad Genetics stock surges on $210M prenatal unit saleInvesting.com Markets · 74Myriad Genetics stock surges on $210M prenatal unit saleThe Fly · sentiment 63 · Myriad Genetics upgraded to Neutral from Underweight at Piper SandlerThe Fly · 63Myriad Genetics upgraded to Neutral from Underweight at Piper SandlerInvesting.com Analyst Ratings · sentiment 52 · TD Cowen holds Myriad Genetics stock rating on Labcorp saleInvesting.com Analyst Ratings · 52TD Cowen holds Myriad Genetics stock rating on Labcorp saleThe Fly · sentiment 63 · TD says Myriad Genetics prenatal divestiture proceeds ahead of expectationsThe Fly · 63TD says Myriad Genetics prenatal divestiture proceeds ahead of expectations
54m agoThe FlyBULLISH 63General

TD says Myriad Genetics prenatal divestiture proceeds ahead of expectations

56m agoInvesting.com Analyst RatingsNEUTRAL 52Analyst

TD Cowen holds Myriad Genetics stock rating on Labcorp sale

TD Cowen holds Myriad Genetics stock rating on Labcorp sale

2h agoThe FlyBULLISH 63Analyst

Myriad Genetics upgraded to Neutral from Underweight at Piper Sandler

2h agoInvesting.com MarketsBULLISH 74M&A

Myriad Genetics stock surges on $210M prenatal unit sale

Myriad Genetics stock surges on $210M prenatal unit sale

4h agoMarketChameleonBULLISH 64M&A

MYGN jumps as Myriad agrees to sell Prenatal Health testing business to Labcorp for $210 million cash

Myriad Genetics (MYGN) announced a definitive agreement to sell its Prenatal Health testing business to Labcorp for $210 million in cash, plus the value of inventory at closing. Myriad said the deal is expected to be accretive to revenue growth and profitability while strengthening its balance sheet, and Labcorp expects about $160 million of year-one revenue and improving diagnostics margins by year two.

4h agoMarketChameleonBULLISH 64M&A

Myriad Genetics strikes $210 million prenatal testing divestiture to sharpen focus on cancer care priorities October 20, 2026

Myriad Genetics announced a definitive agreement to sell its Prenatal Health testing business to Labcorp for $210 million in cash plus inventory value at closing, a move Myriad says will strengthen its balance sheet and support investment in the cancer care continuum. Labcorp expects the acquisition to add about $160 million in year-one revenue, be slightly accretive to adjusted earnings in year one, and reach average diagnostics segment margins by the end of year two.

4h agoSeeking AlphaBULLISH 64M&A

Myriad to sell prenatal health testing business to Labcorp for $210M

Myriad Genetics (MYGN) stock jumps as the company sells its Prenatal Health testing unit to Labcorp in an all-cash deal worth more than $210M. Read more here.

4h agoInvesting.com MarketsBULLISH 64General

Why is Myriad Genetics stock surging today?

Why is Myriad Genetics stock surging today?

5h agoTipRanksBEARISH 44M&A

Myriad Genetics to Divest Prenatal Testing Business

Myriad Genetics ( ($MYGN) ) has shared an update. On October 19–20, 2026, Myriad Genetics and Labcorp announced a definitive agreement under which Myriad will sell ...

5h agoThe FlyBULLISH 58M&A

Myriad Genetics to sell Prenatal Health testing business to Labcorp

Frequently asked questions

Why is MYGN stock moving today?

MYRIAD GENETICS INC (MYGN) is drawing unusual attention today. Our newswire has captured 12 stories on MYGN across 8 sources in the last 36 hours, with AI sentiment reading bullish (avg 60/100). The most recent driver: "TD says Myriad Genetics prenatal divestiture proceeds ahead of expectations" (The Fly).

Is MYGN a buy right now?

Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of MYGN coverage reads 60/100 over 12 stories; treat it as a research signal and do your own diligence.

How fast does this page update?

The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.

More moves explained today

Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →

More on MYGN: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.